Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1. (Q42978681)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Antonio Craxì

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Vito Di Marco

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Daniela Cabibi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Anna Licata

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Giulio Marchesini

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

2

Calogero Cammà

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

4

Nicola Alessi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

8

Stefania Ciminnisi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

5

Francesco Barbaria

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

7

Rosalia Caldarella

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Maria Fatima Massenti

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Alessandra Mazzola

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Giuseppe Tarantino

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

1 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

28-37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18506842%20AND%20SRC:MED&resulttype=core&format=json

Insulin resistance: a metabolic pathway to chronic liver disease

8 January 2020

cites work

1 reference

7 January 2021

STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?

1 reference

7 January 2021

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

1 reference

7 January 2021

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

1 reference

7 January 2021

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

1 reference

7 January 2021

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

1 reference

7 January 2021

Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease

1 reference

7 January 2021

Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis

1 reference

7 January 2021

Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?

1 reference

7 January 2021

Hepatitis C virus: the viral way to fatty liver

1 reference

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

7 January 2021

Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis

1 reference

7 January 2021

Expression of liver steatosis in hepatitis C virus infection and pattern of response to alpha-interferon

1 reference

7 January 2021

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

1 reference

7 January 2021

Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease

1 reference

7 January 2021

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

1 reference

7 January 2021

The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms

1 reference

7 January 2021

Lipocalins and Insulin Resistance: Etiological Role of Retinol-Binding Protein 4 and Lipocalin-2?

1 reference

7 January 2021

Retinol-binding protein: the serum transport protein for vitamin A.

1 reference

7 January 2021

RXR: from partnership to leadership in metabolic regulations

1 reference

7 January 2021

Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?

1 reference

7 January 2021

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

1 reference

7 January 2021

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

1 reference

7 January 2021

Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass

1 reference

7 January 2021

Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease

1 reference

7 January 2021

Retinol binding protein-4 levels and clinical features of type 2 diabetes patients

1 reference

7 January 2021

Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects

1 reference

7 January 2021

Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents.

1 reference

7 January 2021

Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

1 reference

7 January 2021

Retinol-binding protein 4 in human obesity

1 reference

7 January 2021

Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease

1 reference

7 January 2021

High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.

1 reference

7 January 2021

Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation

1 reference

7 January 2021

Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone

1 reference

7 January 2021

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection

1 reference

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

7 January 2021

Clinical significance of the insulin resistance index as assessed by homeostasis model assessment

1 reference

7 January 2021

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

1 reference

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

7 January 2021

Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity

1 reference

7 January 2021

Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes

1 reference

7 January 2021

Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity?

1 reference

7 January 2021

Hepatocyte retinoid X receptor alpha-dependent regulation of lipid homeostasis and inflammatory cytokine expression contributes to alcohol-induced liver injury

1 reference

7 January 2021